Zobrazeno 1 - 10
of 871
pro vyhledávání: '"Steven P Rowe"'
Autor:
Unterrainer M; Die Radiologie, Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. Electronic address: marcus.unterrainer@die-radiologie.de., Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California-Los Angeles, Los Angeles, CA, USA; Bayerisches Zentrum für Krebsforschung Munich, Munich, Germany., Ilhan H; Die Radiologie, Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Publikováno v:
European urology [Eur Urol] 2024 Dec; Vol. 86 (6), pp. e155-e156. Date of Electronic Publication: 2024 Sep 23.
Autor:
Shuch B; Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA. Electronic address: bshuch@mednet.ucla.edu., Raman S; Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA; Department of Radiologic Sciences, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA., Calais J; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, USA.
Publikováno v:
European urology [Eur Urol] 2021 Jul; Vol. 80 (1), pp. e22-e23. Date of Electronic Publication: 2021 Apr 30.
Autor:
Elex S. Harris, Hannah J. McIntire, Marina Mazur, Hinnerk Schulz-Hildebrandt, Hui Min Leung, Guillermo J. Tearney, Stefanie Krick, Steven M. Rowe, Jarrod W. Barnes
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Mucus stasis is a pathologic hallmark of muco-obstructive diseases, including cystic fibrosis (CF). Mucins, the principal component of mucus, are extensively modified with hydroxyl (O)-linked glycans, which are largely terminated by sialic a
Externí odkaz:
https://doaj.org/article/464ad99f1ed345c0bfaeab31f40e7ca1
Autor:
Adrian Constantin Tanjala, Jia Xin Jiang, Paul D. W. Eckford, Mohabir Ramjeesingh, Canhui Li, Ling Jun Huan, Gabrielle Langeveld, Claire Townsend, Daniel V. Paone, Jakob Busch-Petersen, Roman Pekhletski, LiPing Tang, Vamsee Raju, Steven M. Rowe, Christine E. Bear
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Cystic Fibrosis causing mutations in the gene CFTR, reduce the activity of the CFTR channel protein, and leads to mucus aggregation, airway obstruction and poor lung function. A role for CFTR in the pathogenesis of other muco-obst
Externí odkaz:
https://doaj.org/article/2da00d71ae6d4c6493740fb315b80270
Autor:
Rajan Singh, Anand K. Thotakura, Suresh Alati, Alla Lisok, Zirui Jiang, Vanessa F. Merino, Il Minn, Santosh Yadav, Mark C. Markowski, Yasser Ged, Christian P. Pavlovich, Nirmish Singla, Lilja B. Solnes, Michael A. Gorin, Martin G. Pomper, Steven P. Rowe, Sangeeta Ray Banerjee
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRenal cell carcinoma (RCC) represents cancer originating from the renal epithelium and accounts for > 90% of cancers in the kidney. Prostate-specific membrane antigen (PSMA) is overexpressed in tumor-associated neovascular endothelial cel
Externí odkaz:
https://doaj.org/article/0b43bcfa255e43f883bee194298d2a44
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/3a59cca7053246dd8093beb714c1db17
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 548-550 (2024)
Externí odkaz:
https://doaj.org/article/c7638f96410640ec8c6a70999b465a8c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Urology. 80:e22-e23
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Autor:
Nirmish Singla, Thomas R. Nirschl, Aleksandar Z. Obradovic, Eugene Shenderov, Kara Lombardo, Xiaopu Liu, Alice Pons, Jelani C. Zarif, Steven P. Rowe, Bruce J. Trock, Hans J. Hammers, Trinity J. Bivalacqua, Phillip M. Pierorazio, Julie S. Deutsch, Tamara L. Lotan, Janis M. Taube, Yasser M. A. Ged, Michael A. Gorin, Mohamad E. Allaf, Charles G. Drake
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Novel perioperative strategies are needed to reduce recurrence rates in patients undergoing nephrectomy for high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC). We conducted a prospective, phase I trial of neoadjuvant nivolumab
Externí odkaz:
https://doaj.org/article/98ed340a1cfb40a2a956efc49983a1b8